Xalatan


Also found in: Dictionary, Wikipedia.

Xalatan®

Latanoprost Ophthalmology A topical agent for managing open-angle glaucoma and ocular HTN. See Open-angle galucoma.
References in periodicals archive ?
No such studies were required from generic manufacturers whose latanoprost formulations were very similar to that of the original Xalatan.
Xalatan eye drops are used for the treatment of glaucoma and high eye pressure.
A link between the use of Xalatan or brimonidine and dementia has not been reported, although brimonidine can cause somnolence (sleepiness) and insomnia.
In terms of the government's bottom line, taxpayers who do not use Xalatan were not ripped off by the R&D subsidy, and those who do use the drug presumably benefited enough to make any taxes included in the drug's cost worthwhile.
There have been no new-class drugs developed for Glaucoma for 20 years, since Pfizer introduced Xalatan (latanaprost).
But this did not prevent me from frantically scribbling down information about the pros and cons of generic Xalatan and promising myself that I would look into the article mentioned about current and emerging glaucoma medications.
Your eye doctor may prescribe Azopt, Cosopt, Lumigan, Timolol, Timoptic, Travatan, Trusopt, or Xalatan, among others.
Last April, The New York Times ran a news story suggesting that although some of the original research on Xalatan was backed by a $4 million NIH grant in 1982, the "taxpayers have reaped no financial reward on their investment.
There have been no new class drugs developed for Glaucoma for 20 years, since Pfizer introduced Xalatan (latanaprost).
The HES was contacted and this conversation revealed that the gentleman was supposed to be instilling atropine and predforte into the blind eye for ocular comfort and xalatan in the right eye.
patent protection and includes the patent lapses of Xalatan and Aromasin in the first half of 2011.
There has been a small retrograde step recently in the UK with the NICE recommendation that prostaglandin analogues are not recommended first line therapy in the under 65s, on the grounds of cost, but this may change as Xalatan will shortly go off patent and so these drugs will fall in price.